ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics Share Discussion Threads

Showing 39876 to 39899 of 41850 messages
Chat Pages: Latest  1602  1601  1600  1599  1598  1597  1596  1595  1594  1593  1592  1591  Older
DateSubjectAuthorDiscuss
29/6/2018
14:54
Good Luck Hyper
sikhthetech
29/6/2018
14:51
Indeed Hyper ... all the very best to you with your fine venture. HM
hugus maximus
29/6/2018
12:56
Gonna blow...
cantrememberthis2
29/6/2018
12:16
You'll make a fine job of it. Good luck Hyper.
waterloo01
29/6/2018
11:31
Got a seller more likely a heavy PI hitting it at every tick upabove 34p... MMs happy to pick up off...
Oversold and Bollinger's are tightening... Grossly oversold giving no value to their pipeline just cash in bank...

cantrememberthis2
29/6/2018
10:08
chart looks primed for upward movement...cash plus other pipeline products should see this recover from here..mm's overshoot and rsi picking moving in right direction.
pre
29/6/2018
09:55
Need seller to be cleared and done... Still lurking
cantrememberthis2
29/6/2018
08:07
Looks good now overhang cleared these will potentially be over 50p shortly
kirk 6
28/6/2018
20:36
Summit have approximately £22.5m+ cash in the bank if you take off May and June 2018 expenditure.
However, one cannot disregard a Phase 3 Trial and the potential uplift to share price prior to commencement.
As for placings etc, I would support placings as we all have done in other stocks. It comes with the territory.
OXB paid off handsomely.
ANTIBIOTICS are the future bugbear and will need massive boosts in R&D.

This could re-rate massively in any antibiotic headaches across the globe.

Discuva was a SENSIBLE play and the board knew the Phase 2 DMD was risk based too.

Make of that as you wish.

I care not, SUMMIT is not a busted flush and I think everyone needs reminding that the share price is barely taking into account their pipeline, Phase 3 Trial, Discuva and DATA from DMD (££ valuable research data).

Game on

cantrememberthis2
28/6/2018
20:19
My average is about 39p made huge profits elsewhere so been looking for a short term home.
kirk 6
28/6/2018
19:51
Kirk really? You got double my holdings... Your loss here on bid price must be large... Mine is big due to spread.
cantrememberthis2
28/6/2018
19:41
Holding 130k shares here now bought another 50k today. Will add another 50k tomorrow
kirk 6
28/6/2018
19:26
Oh I'm sorry nic.
I beg your forgiveness my lord.
You are my god.
I love you.

cantrememberthis2
28/6/2018
19:19
U r foolish every buyer is matched by a sellerIf you can't fathom that out maybe you shouldn't be investing
nico115
28/6/2018
19:00
Kirk unlike IMM and FARN we have no chatter or pump and dump crew.
So highly unusual that the share price Take No Account of £10m Discuva acquisition or indeed the IPR. Barely factors in £25m cash in the bank with immediate reduction in spend nor the promising pipeline(s).
Also a Phase 3 Trial in 6 months....
Whereas IMM and Farn bounced massively to then come down.
Holding 62k shares... Its peeps like me who have absorbed the sellers.

cantrememberthis2
28/6/2018
18:27
These must be due a re rate shortly
kirk 6
28/6/2018
17:04
There you have it 35p seller... Cleared for take off.
Gla

cantrememberthis2
28/6/2018
16:29
Indeed Chris ... I think you're referring to the DMD pipeline which was seemingly extensive. I've searched for responses from Dame Kay but so far nothing. She must be gutted after 20 years without seemingly anything positive to followup on? Nothing remotely to do with either her SMTC1100 or any sort of utrophin regulation ... all so incredibly tragic.
hugus maximus
28/6/2018
15:19
Chris it's related to DMD...why would they talk about anything else.
Strong buy.

cantrememberthis2
28/6/2018
15:17
Update on Summit website today:

On June 27, 2018, Summit announced the top line data from PhaseOut DMD, a Phase 2 proof of concept trial evaluating the small molecule utrophin modulator, ezutromid.

A letter to the DMD Community was published and a copy of this can be found below.



Edit: Looks pretty final to me not a mention of other drugs in the 'pipeline'.

chrisatrdg
28/6/2018
14:12
Looks good

hxxp://marketrealist.com/2018/06/why-summit-therapeutics-stock-crashed-yesterday/?utm_source=market-watch-headline&utm_medium=feed&utm_content=main_permalink&utm_campaign=why-summit-therapeutics-stock-crashed-yesterday

cantrememberthis2
28/6/2018
13:34
damien - yet i have been trading for many, many years - surprised you've even heard of AMI given your newbie status. If you really think that was a buy then more fool you!
wooster4
28/6/2018
13:17
Well some of s see value here..I've got 62k shares here..with only 82m shares that's a fair whack. Will keep loading...as below cash and IPR value
cantrememberthis2
28/6/2018
13:05
Who cares?

Well people who bought would care. Is that difficult to understand?

who cares if you are steering clear? Maybe it's good that you stay clear, but most do not care what you or anyone else do, in reality.

deadly heisenberg
Chat Pages: Latest  1602  1601  1600  1599  1598  1597  1596  1595  1594  1593  1592  1591  Older

Your Recent History

Delayed Upgrade Clock